Management of hepatitis B virus co-infection on and off antiretroviral therapy (Q37176668)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2008

edit

Language	Label	Description	Also known as
English	Management of hepatitis B virus co-infection on and off antiretroviral therapy	scientific article published on May 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Management of hepatitis B virus co-infection on and off antiretroviral therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

main subject

anti-retroviral agent

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author

Julie Sheldon

object named as

Julie Sheldon

series ordinal

4

0 references

Vicente Soriano

series ordinal

1

object named as

Vincent Soriano

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

author name string

Eugenia Vispo

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

Marcelle Bottecchia

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

Paula Tuma

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

Javier Garcia-Samaniego

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

Pablo Barreiro

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

publication date

1 May 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

published in

Current HIV/AIDS reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

page(s)

86-93

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

cites work

Hepatitis B virus taxonomy and hepatitis B virus genotypes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11904-008-0014-4

retrieved

21 January 2018

Antiviral therapy and resistance with hepatitis B virus infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11904-008-0014-4

retrieved

21 January 2018

Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11904-008-0014-4

retrieved

21 January 2018

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11904-008-0014-4

retrieved

21 January 2018

A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

More severe course of delta hepatitis in HIV-infected patients [L]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients co-infected with hepatitis B virus and HIV.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment algorithm for chronic hepatitis B in HIV-infected patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delta hepatitis: an update

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with interferons (including pegylated interferons) in patients with hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk and predictors of mortality associated with chronic hepatitis B infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus with primary resistance to adefovir.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of HIV/HBV coinfection: clinical and virologic issues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of viral hepatitis and HIV co-infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of chronic hepatitis B and C in HIV-coinfected patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variation in HBV infection: genotypes and mutants

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black box.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hepatitis B: summary of a clinical research workshop

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of chronic hepatitis B in co-infected patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus escape mutants induced by antiviral therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variant of hepatitis B virus with primary resistance to adefovir

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiviral options for the treatment of chronic hepatitis B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis D.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HBV drug entecavir - effects on HIV-1 replication and resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telbivudine: a new option for the treatment of chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of HIV and hepatitis B coinfection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-steady-state kinetic studies establish entecavir 5'-triphosphate as a substrate for HIV-1 reverse transcriptase.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18510894

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11904-008-0014-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

PubMed publication ID

18510894

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18510894

retrieved

18 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37176668&oldid=2199979236"